| Literature DB >> 26107938 |
Flore Amat1, Philippe Saint-Pierre2, Emmanuelle Bourrat3, Ariane Nemni4, Rémy Couderc5, Emmanuelle Boutmy-Deslandes6, Fatiha Sahraoui4, Isabelle Pansé3, Martine Bagot3, Sébastien Foueré3, Jocelyne Just1.
Abstract
BACKGROUND: Atopic dermatitis (AD) is known to predate asthma and other atopic disorders described under the term "atopic march". However, this classic sequence is not always present and only a few studies have addressed children at risk of developing asthma. The objective of this study is to define early-onset AD phenotypes leading to asthma.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26107938 PMCID: PMC4479437 DOI: 10.1371/journal.pone.0131369
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Clinical parameters at inclusion in the entire cohort and according to cluster analysis.
| Parameters | Entire cohort n = 214 | Cluster 1AD | Cluster 2AD with MS | Cluster 3AD with FHA | p-value |
|---|---|---|---|---|---|
|
| 8.51 +/- 2.79 | 8.08 +/- 2.92 | 8.76 +/- 2.50 | 9.09 +/- 2.96 | 0.13 |
|
| 57.9 | 63.8 | 56 | 50 | 0.30 |
|
| 28.04 +/-16 | 25.29 +/- 14.6 | 32.66 +/- 16.6 | 24.46 +/- 15.7 |
|
|
| 34.1 | 1.1 | 42.9 | 100 |
|
|
| 11.7 | 1.1 | 21.4 | 2.3 |
|
|
| 5.6 | 0 | 14.3 | 0 |
|
|
| 3.3 | 0 | 8.3 | 0 |
|
|
| 36 | 27.7 | 41.7 | 44.4 | 0.07 |
|
| 51.9 | 53.2 | 48.8 | 55.6 | 0.75 |
|
| 0.5 | ||||
|
| 37 | 39.6 | 39.2 | 24.2 | |
|
| 37 | 37.4 | 32.9 | 45.5 | |
|
| 26.1 | 23.1 | 27.9 | 30.3 | |
|
| 22 | 16 | 29.8 | 19.4 | 0.07 |
|
| 0.11 | ||||
|
| 48 | 37.3 | 50.8 | 64.5 | |
|
| 23.4 | 29.9 | 24.6 | 12.9 | |
|
| 28.7 | 33 | 24.6 | 22.6 |
All values for categorial or qualitative variables given as percentages. Boldfaced text indicates statistical significance.
1AD = atopic dermatitis
2LS = low sensitization
3MS = multiple sensitizations
4FHA = familial history of asthma.
5SD = standard deviation
6Analysis of variance and Chi-2 test when conditions allowed, Kruskal-Wallis and Fischer's exact test otherwise.
Biological parameters at inclusion in the entire cohort and according to cluster analysis.
| Parameters | Entire cohort | Cluster 1 AD | Cluster 2AD with MS | Cluster 3 AD with FHA | p-value |
|---|---|---|---|---|---|
| n = 214 | n = 94 | n = 84 | n = 36 | ||
|
| 114.6 +/- 322.7 | 34.8 +/- 86.6 | 241.8 +/- 482.9 | 31.3 +/- 44.3 |
|
|
| 354 +/- 543 | 242.5 +/- 285.1 | 554.9 +/- 760.9 | 186.2 +/- 248.4 |
|
|
| 57.5 | 27.7 | 98.9 | 38.9 |
|
|
| 38.8 | 2.3 | 96.4 | 0 |
|
|
| 54.2 | 28.7 | 86.9 | 44.4 |
|
|
| 6.6 +/- 15.2 | 1.9 +/- 5.9 | 14 +/- 21.4 | 1.5 +/- 3.6 |
|
|
| 49.1 | 5.3 | 72.6 | 8.3 |
|
|
| 1.5 +/- 4.9 | 0.1 +/- 0.6 | 3.7 +/- 7.2 | 0.2 +/- 0.9 |
|
|
| 30.8 | 5.3 | 70.2 | 5.6 |
|
|
| 3.2 +/- 12.8 | 0.2 +/- 1.4 | 7.8 +/- 19.5 | 0.1 +/- 0.3 |
|
|
| 1.9 | 0 | 4.8 | 0 |
|
|
| 0.8 +/- 0.7 | - | 0.2 +/- 0.1 | - | 0.2 |
|
| 3.7 | 1.1 | 8.3 | 0 |
|
|
| 0.2 +/- 1.8 | 0 +/- 0.4 | 0.5 +/- 2.8 | - |
|
|
| 14.9 | 10.6 | 26.2 | 0 |
|
|
| 3.3 | 1.1 | 7.1 | 0 |
|
|
| 3.3 | 3.2 | 3.6 | 2.8 | 0.97 |
|
| 0.2 +/- 1.3 | 0.29 +/6 1.8 | 0.09 +/- 0.55 | 0.04 +/- 0.3 | 0.82 |
|
| 12.6 | 8.5 | 22.6 | 0 |
|
|
| 0.8 +/- 6.9 | 0.1 +/- 0.4 | 1.9 +/- 1.1 | - |
|
|
| 2.3 | 0 | 5.9 | 0 |
|
|
| 0.01 +/- 0.1 | - | 0 +/- 0.2 | - |
|
|
| 0.5 | 0 | 1.2 | 0 | 0.5 |
|
| 0.01 +/- 0.2 | - | 0 +/- 0.3 | - | 0.46 |
All values for categorial or qualitative variables given as percentages. Boldfaced text indicates statistical significance.
1AD = atopic dermatitis
2LS = low sensitization
3MS = multiple sensitizations
4FHA = familial history of asthma.
5SD = standard deviation
6Analysis of variance and Chi-2 test when conditions allowed, Kruskal-Wallis and Fischer's exact test otherwise.Boldfaced text indicates statistical significance.
Fig 1Dendogram for the entire population (n = 214), obtained with a hierarchical bottom-up clustering.
Three clusters were apparent. This agglomerative approach begins with each subject as a separate cluster and merges them into successively larger clusters. By Ward’s linkage, samples were merged into larger clusters to minimize the within-cluster sum of squares. Cluster 1: “AD with low sensitization”, cluster 2: “AD with multiple sensitizations”, cluster 3: “AD with familial history of asthma”.
Parameters at the end of the follow-up (6 years).
| Outcomes | Entire cohort n = 214 | Cluster 1 AD | Cluster 2 AD with MS | Cluster 3 AD with FHA | p-value |
|---|---|---|---|---|---|
|
| 47.5 | 47.1 | 40.5 | 64.7 | 0.06 |
|
| 26.6 | 14.9 | 36.1 | 33.3 |
|
|
| 21 | 12.6 | 30.5 | 27.3 |
|
All values given as percentages. Boldfaced text indicates statistical significance.
1AD = atopic dermatitis
2LS = low sensitization
3MS = multiple sensitizations
4FHA = familial history of asthma.
5Analysis of variance and Chi-2 test when conditions allowed, Kruskal-Wallis and Fischer's exact test otherwise.Boldfaced text indicates statistical significance.
Fig 2Classification tree for the entire cohort based on two variables.
Each subject was assigned to one of the 3 clusters using the tree; 97% of the subjects were assigned to the appropriate cluster. Tree performance values are given in the table. Cluster 1: “AD with low sensitization”, cluster 2: “AD with multiple sensitizations”, cluster 3: “AD with familial history of asthma”.
Fig 3Importance measure (permutation-based mean decrease accuracy) provided by the random forest analysis.
The values are not interpretable but the ranking is of interest since a high value of the importance measure is associated with a high predictive power. Sensitization is defined by specific IgE to one or more allergens ≥0.35 kUI/L. Multiple sensitizations were defined as at least two positive specific IgEs to allergens. Serum total IgE level expressed in kU/L, blood eosinophilia expressed in eosinophils/mm3